23 /100
LOW RISK
Score updated May 29, 2026

RNAC — Cartesian Therapeutics, Inc. Dilution Risk Tracker

Track RNAC dilution risk with DilutionWatch's stock tracker. DilutionScore™ measures dilution risk across 5 factors — lower scores indicate higher risk of share dilution.

⚠️ Not financial advice. Do your own research before making any investment decisions.

🔔 Track RNAC — Get alerts when the score changes →

📊 Score Breakdown

📋 Offering Ability
20
💰 Cash Runway
10
📊 Float Risk
70
⚠️ Warrant Exposure
15
🔄Convertible Debt

🌦️ Dilution Forecast

☀️
Clear
No significant dilution signals
0%
No significant dilution signals detected for RNAC.
🔔 Track RNAC — Get forecast alerts →

💹 Market Data

Market Cap$211.84M
Shares Outstanding29.38M
Float9.57M
Cash$118.64M
Debt$11.86M
Short InterestN/A

🏛 Institutional Holdings

QoQ: ↓ 14.4% shares (2025Q4 vs prior)
69 institutional holders · 5.29M shares
#1 FMR LLC 1.37M shares
#2 BlackRock, Inc. 609.7K shares
#3 VANGUARD GROUP INC 541.2K shares
+ 17 more holders Sign up free to view →

📉 Short Interest

Short Interest2.17M
Days to Cover12.8
% of Float22.7%
FINRA data as of Apr 30, 2026

📁 Recent SEC Activity

xbrl XBRL WARRANT Mar 31, 2026
xbrl XBRL CONVERTIBLE Dec 31, 2016
4 INSIDER TRANSACTION Apr 06, 2026
4 INSIDER TRANSACTION Apr 06, 2026
4 INSIDER TRANSACTION Mar 13, 2026
Full SEC filing analysis available with free account

📰 Recent News

No recent news
Track RNAC Dilution Risk in Real-Time
Get instant alerts when SEC filings impact dilution risk. Free tier available.
Start Tracking RNAC — Free
Real-time SEC alerts DilutionScore™ tracking No credit card required
🔬 More Research for RNAC
📊 RNAC FDA Catalyst Timeline & Biotech Grade — BiotechSigns 📡 RNAC Signal Convergence & Dark Pool Activity — StonkWhisper

Part of the Guerilla Finance research network. Cross-reference multiple data sources for better due diligence.